Abril 2011

- Alpha linolenic acid and contribution to brain and nerve tissue development (EFSA-Q-2009-00197)

Febrero 2011

- Thiamin and maintenance of normal neurological development and function (EFSA-Q-2009-00455)

Julio 2010

- Health claim related to thiamine and carbohydrate and energy-yielding metabolism (EFSA-Q-2008-183)

Marzo 2010

- Eye qTM and working memory (EFSA Q-2009-00485)

Febrero 2010

- Immunofortis® and strengthening of the baby’s immune system (EFSA-Q-2008-106)

Noviembre 2009

- Iodine and the growth of children (EFSA-Q-2008-324)

- Iron and cognitive development of children (EFSA-Q-2008-325)

Abril 2009

- ALA and contribution to brain development (EFSA Q-2008-666)

- DHA and support of the cognitive development of the unborn child and breastfed infant (EFSA Q-2008-773)

- DHA and support of the visual development of the unborn child and breastfed infant (EFSA Q-2008-675)

Marzo 2009

- Lipil® and visual development (EFSA-Q-2008-688)

- Enfamil® Premium and brain development (EFSA-Q-2008-691)

- Enfamil® Premium and visual development (EFSA-Q-2008-689)

- DHA and ARA and brain development (EFSA-Q-2008-212)

- Lipil® and brain development (EFSA-Q-2008-690)

- Follow-on formulae with bioactive constituents and intestinal ailments (EFSA Q-2008-270)

Febrero 2009

- DHA and ARA and visual development - Scientific substantiation of a health claim related to docosahexaenoic acid (DHA) and arachidonic acid (ARA) and visual development (EFSA Q-2008-211)

- Kinder Chocolate® and growth - Scientific substantiation of a health claim related to Kinder Chocolate® and growth (EFSA Q-2008-283)

Enero 2009

- Dairy fresh cheese and bone growth (EFSA Q-2008-217)

Diciembre 2008

- LACTORAL and living probiotic bacteria (EFSA Q-2008-480)

- LACTORAL and improvement of the general immunity (EFSA Q-2008-477)

- LACTORAL and normal functioning of the alimentary tract (EFSA Q-2008-269)

- LACTORAL and maintenance of natural intestinal microflora during travel (EFSA Q-2008-479)

-   LACTORAL and building of the natural intestinal barrier (EFSA Q-2008-478)

- Mumomega® and central nervous system development (EFSA-Q-2008-328)

- Efalex® and coordination (EFSA-Q-2008-121)

- Efalex® and brain development and function (EFSA-Q-2008-318)

-  Efalex® and concentration (EFSA-Q-2008-317)

- Efalex® and eye development and function (EFSA-Q-2008-320)

- Efalex® and learning ability (EFSA-Q-2008-319)

- Eye q® and brain functions (EFSA-Q-2008-329)

- Eye q baby® and central nervous system development (EFSA-Q-2008-119)

-  Eye q® and concentration (EFSA-Q-2008-330)

Noviembre 2008

- Animal protein and bone growth - (EFSA Q-2008-326)

Octubre 2008

- Regulat®.pro.kid BRAIN and mental and cognitive development of children - (EFSA Q-2008-083)

- SI omega kids®/Pufan 3 kids® and serenity - (EFSA Q-2008-097)

- I omega kids®/Pufan 3 kids® and calming - (EFSA Q-2008-096)

- I omega kids®/Pufan 3 kids® and vision  (EFSA Q-2008-100)

- Vitamin D and bone growth -  (EFSA Q-2008-323)

- Calcium and vitamin D and bone strength - (EFSA Q-2008-116)

- Calcium and bone growth - (EFSA Q-2008-322)

- I omega kids®/Pufan 3 kids® and mental development - (EFSA Q-2008-098)

- I omega kids®/Pufan 3 kids® and concentration -(EFSA Q-2008-094 y 099)

- I omega kids®/Pufan 3 kids® and thinking capacity - (EFSA Q-2008-093 y 101)

- I omega kids®/Pufan 3 kids® and learning ability -  (EFSA Q-2008-102 y 103)

Septiembre 2008

- DHA and ARA and development of brain and eyes -  (EFSA Q-2008-120)